Orchestra BioMed
OBIO
OBIO
56 hedge funds and large institutions have $81.3M invested in Orchestra BioMed in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.68% less ownership
Funds ownership: 50.65% → 49.97% (-0.68%)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
Holders
56
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$357K | |
| 2 | +$111K | |
| 3 | +$98.4K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$89.1K |
| 5 |
MCM
Massar Capital Management
Stamford,
Connecticut
|
+$42.8K |
Top Sellers
| 1 | -$953K | |
| 2 | -$160K | |
| 3 | -$142K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$116K |
| 5 |
Millennium Management
New York
|
-$86.1K |
